Back/InfoComm EDGE Dubai Showcases AV Solutions Enabling Biotech Collaboration, Aiding PDS Biotechnology
biotech·February 8, 2026·pdsb

InfoComm EDGE Dubai Showcases AV Solutions Enabling Biotech Collaboration, Aiding PDS Biotechnology

ED
Editorial
Cashu Markets·2 min read
TL;DR
  • InfoComm EDGE could provide AV solutions PDS Biotechnology needs for complex clinical programs and remote GCC collaborations.
  • Demonstrations help PDS decision-makers visualize remote patient monitoring, virtual tumor boards, staff training, and secure clinical trial coordination.
  • Standards-based, demonstrable systems offer PDS a way to align operations, regulatory compliance, and patient-facing technologies in the region.

Dubai Pro AV Showcase Signals New Tools for Biotech Collaboration

InfoComm EDGE’s experiential format in Dubai could provide practical audiovisual solutions that companies such as PDS Biotechnology need to run complex clinical programs and remote collaborations across the Gulf Cooperation Council (GCC), industry executives say. AVIXA is hosting the two‑day event on Oct. 27–28, 2026 at the Festival Arena to let senior buyers across government, enterprise, education, retail, leisure and entertainment see, touch and experience standards‑aligned pro AV innovation in buyer‑focused activations rather than vendor pitches.

InfoComm EDGE’s approach is particularly relevant to the biotech sector because it emphasizes integrated, narrative‑led demonstrations that mirror end‑to‑end project delivery. The Festival Arena layout centres a live activation stage and supporting pods rather than a traditional trade‑show grid, allowing systems integrators to show combined audiovisual, telepresence and data‑visualization workflows. For PDS Biotechnology, which operates in regulated clinical and research environments, such demonstrations help decision‑makers visualise solutions for remote patient monitoring, virtual tumour boards, staff training and secure clinical trial coordination before procurement and deployment decisions.

The event’s co‑creative model, in which local integrators design and staff activations, aims to reduce implementation risk and improve outcomes by highlighting standards, integration and delivery excellence. AVIXA Chief Executive David Labuskes points to the GCC’s appetite and resources for innovation, while Event Director Cara Turner stresses that high‑level buyers struggle to picture complex systems from booth displays. For PDS and peers in the biotech and healthcare sectors, the emphasis on demonstrable, standards‑based systems offers a path to align operational needs, regulatory compliance and patient‑facing technologies in the region.

Other industry implications

InfoComm EDGE opens an avenue for manufacturers and integrators to partner directly with healthcare and life‑sciences buyers, presenting opportunities to influence specification and procurement for new facilities and retrofits. The narrative‑led format is pitched at reducing risk in capital projects, an issue biotech firms often cite when planning trial sites, training centres or telemedicine hubs.

Event details and participation

Branded “Where the Art of the Possible Becomes Reality,” the two‑day event uses more than 7,200 square metres of indoor and outdoor space and invites AV integrators, manufacturers and prospective attendees to submit designs, sponsorships and registration inquiries at AVIXA’s InfoComm EDGE Dubai web portal.

Cashu Markets
Cashu
Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Markets
Cashu
Markets

Setting up your session...